The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Moser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663
Qualitative alteration in substrate specificity of mitochondrial monoamine oxidase in brain
Moskvitina, T. A., Kamyshanskaya, N. S., Kaverina, L. P., & Gorkin, V. Z. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb04462.x · Cited by 440
Kamijo, K., Taketani, S., Yokota, S., Osumi, T., & Hashimoto, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39595-x · Cited by 391
Aubourg, P., Blanche, S., Jambaqué, I., Rocchiccioli, F., Kalifa, G., Naud-Saudreau, C., Rolland, M.-O., Debré, M., Chaussain, J.-L., Griscelli, C., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222607 · Cited by 366
Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening
Bezman, L., Moser, A. B., Raymond, G. V., Rinaldo, P., Watkins, P. A., Smith, K. D., Kass, N. E., & Moser, H. W. (2001) · Annals of Neurology · doi:10.1002/ana.101 · Cited by 324
Kemp, S., Pujol, A., Waterham, H. R., van Geel, B. M., Boehm, C. D., Raymond, G. V., Cutting, G. R., Wanders, R. J. A., & Moser, H. W. (2001) · Human Mutation · doi:10.1002/humu.1227 · Cited by 321
A mouse model for X-linked adrenoleukodystrophy
Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293 · cited 1×
“For the third X-ALD mouse [88], a silent mutation wa insertion of the neo gene.”
BackgroundThe gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein
Mosser, J., Lutz, Y., Stoeckel, M. E., Sarde, C. O., Kretz, C., Douar, A. M., Lopez, J., Aubourg, P., & Mandel, J. L. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.2.265 · Cited by 281
Expression of PEX11β Mediates Peroxisome Proliferation in the Absence of Extracellular Stimuli
Schrader, M., Reuber, B. E., Morrell, J. C., Jimenez-Sanchez, G., Obie, C., Stroh, T. A., Valle, D., Schroer, T. A., & Gould, S. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29607 · Cited by 266
POWERS, J. M., LIU, Y., MOSER, A. B., & MOSER, H. W. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199211000-00007 · Cited by 265
Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
Kemp, S., Wei, H.-M., Lu, J.-F., Braiterman, L. T., McGuinness, M. C., Moser, A. B., Watkins, P. A., & Smith, K. D. (1998) · Nature Medicine · doi:10.1038/3242 · Cited by 249
A Two-Year Trial of Oleic and Erucic Acids (“Lorenzo's Oil”) as Treatment for Adrenomyeloneuropathy
Aubourg, P., Adamsbaum, C., Lavallard-Rousseau, M.-C., Rocchiccioli, F., Cartier, N., Jambaque, I., Jakobezak, C., Lemaitre, A., Boureau, F., Wolf, C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309093291101 · Cited by 242
Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil
Moser, H. W., Raymond, G. V., Lu, S.-E., Muenz, L. R., Moser, A. B., Xu, J., Jones, R. O., Loes, D. J., Melhem, E. R., Dubey, P., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1073 · Cited by 239
Adrenoleukodystrophy: Phenotypic variability and implications for therapy
Moser, H. W., Moser, A. B., Smith, K. D., Bergin, A., Borel, J., Shankroff, J., Stine, O. C., Merette, C., Ott, J., Krivit, W., et al. (1992) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799621 · Cited by 239
Pujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214 · cited 1×
“Abnormal neurological and behavioural phenotypes as well as slower nerve conduction and myelin and axonal anomalies in the spinal cord and sciatic nerve start around 15 months of age [90].”
BackgroundPujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., Ruiz, M., Pàmpols, T., Giròs, M., & Mandel, J. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh323 · Cited by 201 · cited 2×
“Upon overexpression ALDRP can functionally compensate for ALDP deficiency in X-ALD fibroblasts and Abcd1-deficient mice [93,97].”
BackgroundMethodKobayashi, T., Shinnoh, N., Kondo, A., & Yamada, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6340 · Cited by 197
Shani, N., & Valle, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11901 · Cited by 157
Netik, A., Forss-Petter, S., Holzinger, A., Molzer, B., Unterrainer, G., & Berger, J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.907 · Cited by 148
Self-citationRole of ALDP (ABCD1) and Mitochondria in X-Linked Adrenoleukodystrophy
McGuinness, M. C., Lu, J.-F., Zhang, H.-P., Dong, G.-X., Heinzer, A. K., Watkins, P. A., Powers, J., & Smith, K. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.744-753.2003 · Cited by 147
Eichler, E. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.991 · Cited by 143
Ito, M., Blumberg, B. M., Mock, D. J., Goodman, A. D., Moser, A. B., Moser, H. W., Smith, K. D., & Powers, J. M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.10.1004 · Cited by 125
Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system
Fouquet, F., Zhou, J. M., Ralston, E., Murray, K., Troalen, F., Magal, E., Robain, O., Dubois-Dalcq, M., & Aubourg, P. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0127 · Cited by 115
Spastic paraplegia associated with Addison’s disease: Adult variant of adreno-leukodystrophy
Budka, H., Sluga, E., & Heiss, W.-D. (1976) · Journal of Neurology · doi:10.1007/bf00312873 · Cited by 115
Berger, J., Albet, S., Bentejac, M., Netik, A., Holzinger, A., Roscher, A. A., Bugaut, M., & Forss‐Petter, S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00772.x · Cited by 106
Self-citationMutational analysis of patients with X-linked adrenoleukodystrophy
Kok, F., Neumann, S., Sarde, C.-O., Zheng, S., Wu, K.-H., Wei, H.-M., Bergin, J., Watkins, P. A., Gould, S., Sack, G., et al. (1995) · Human Mutation · doi:10.1002/humu.1380060203 · Cited by 103
Primary Structure of Human PMP69, a Putative Peroxisomal ABC-Transporter
Holzinger, A., Kammerer, S., & Roscher, A. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7102 · Cited by 91
Asheuer, M., Bieche, I., Laurendeau, I., Moser, A., Hainque, B., Vidaud, M., & Aubourg, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi140 · Cited by 86
Kishimoto, Y., Moser, H. W., Kawamura, N., Platt, M., Pallante, S. L., & Fenselau, C. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)91182-1 · Cited by 79
Kemp, S., Ligtenberg, M. J. L., Vangeel, B. M., Barth, P. G., Wolterman, R. A., Schoute, F., Sarde, C. O., Mandel, J. L., Vanoost, B. A., & Bolhuis, P. A. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1979 · Cited by 75
Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation
Maier, E. M., Kammerer, S., Muntau, A. C., Wichers, M., Braun, A., & Roscher, A. A. (2002) · Annals of Neurology · doi:10.1002/ana.10376 · Cited by 72
PRESIDENTIAL ADDRESS: The Pathology of Peroxisomal Disorders with Pathogenetic Considerations
Powers, J. M. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199509000-00014 · Cited by 67
Naidu, S. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520320032011 · Cited by 55
Evaluation of pharmacological induction of fatty acid β-oxidation in X-linked Adrenoleukodystrophy
McGuinness, M. C., Zhang, H.-P., & Smith, K. D. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3239 · Cited by 51
Dvoráková, L., Štorkánová, G., Unterrainer, G., Hujová, J., Kmoch, S., Zeman, J., Hrebícek, M., & Berger, J. (2001) · Human Mutation · doi:10.1002/humu.1149 · Cited by 23
Self-citationGray, R. G. F., Green, A., Cole, T., Davidson, V., Giles, M., Schutgens, R. B. H., & Wanders, R. J. A. (1995) · Prenatal Diagnosis · doi:10.1002/pd.1970150514 · Cited by 23
Pitfalls in the prenatal diagnosis of peroxisomal β‐oxidation defects by chorionic villus sampling
Carey, W. F., Poulos, A., Sharp, P., Nelson, P. V., Robertson, E. F., Hughes, J. L., & Gill, A. (1994) · Prenatal Diagnosis · doi:10.1002/pd.1970140909 · Cited by 22
Adreno-leukodystrophy: A personal historical note
Powers, J. M. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0961-9 · Cited by 15
Research works printed but not linked: 85
- Haberfeld, 1910, Zur diffusen Hirn-Rückenmarksclerose im Kindesalter, Dtsch. Z. Nervenheilkd., 40, 436, 10.1007/BF01629013 · DOI
- Schilder, 1912, Zur Kentniss der sogenannten diffusen Sklerose, Z. Gesamte Neurol. Psychiatr., 10, 1, 10.1007/BF02901445 · DOI · Paper page
- Siemerling, 1923, Bronzekrankheit und sklerosierende Encephalomyelitis, Arch. Psychiatr Nervkrankh., 68, 217, 10.1007/BF01835678 · DOI
- Fanconi, 1963, Morbus Addison mit Hirnsklerose im Kindesalter: ein hereditaeres Syndrom mit X-chromosomaler Vererbung?, Helv. Paediatr. Acta, 18, 480
- Griffin, 1977, Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy: I. Clinical and endocrinologic aspecrs, Neurology, 27, 1107, 10.1212/WNL.27.12.1107 · DOI · Paper page
- Dobyns, 2004, Inheritance of most X-linked traits is not dominant or recessive, just X-linked, Am. J. Med. Genet., 129, 136, 10.1002/ajmg.a.30123 · DOI · Paper page
- Restuccia, 1997, Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement, Brain, 120, 1139, 10.1093/brain/120.7.1139 · DOI · Paper page
- van Geel, 1997, X-linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy, J. Neurol. Neurosurg. Psychiatry, 63, 4, 10.1136/jnnp.63.1.4 · DOI · Paper page
- Migeon, 1981, Adrenoleukodystrophy: evidence for X-linkage, inactivation and selection favoring the mutant allele in heterozygous cells, Proc. Natl. Acad. Sci. U. S. A., 78, 5066, 10.1073/pnas.78.8.5066 · DOI · Paper page
- Oberle, 1985, The telomere of the human X-chromosom long arm: presence of a highly polymorphic DNA marker and analysis of recombination frequency, Proc. Natl. Acad. Sci. U. S. A., 82, 2824, 10.1073/pnas.82.9.2824 · doi:10.1073/pnas.82.9.2824
- Aubourg, 1987, Linkage of adrenoleukodystrophy to a polymorphic DNA probe, Ann. Neurol., 21, 349, 10.1002/ana.410210406 · DOI
- Holzinger, 1999, Full length cDNA cloning, promoter sequence and genomic organisation of the human adrenoleukodystrophy related (ALDR) gene functionally redundant to the gene responsible for X-linked adrenoleukodystrophy, Biochem. Bioph. Res. Commun., 258, 436, 10.1006/bbrc.1999.0535 · DOI
- Berger, 1994, X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes, Biochem. Biophys. Res. Commun., 205, 1638, 10.1006/bbrc.1994.2855 · DOI · Paper page
- Smith, 1999, X-linked adrenoleukodystrophy: genes, mutations, and phenotypes, Neurochem. Res., 24, 521, 10.1023/A:1022535930009 · DOI · Paper page
- Korenke, 1996, Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype, Ann. Neurol., 40, 254, 10.1002/ana.410400221 · DOI · Paper page
- Yatsenko, 2001, Late-onset Stargardt disease is associated with missense mutations that map outside known functional regions of ABCR (ABCA4), Hum. Genet., 108, 346, 10.1007/s004390100493 · DOI
- Higgins, 1992, ABC transporters. From microorganisms to man, Annu. Rev. Cell Biol., 8, 67, 10.1146/annurev.cb.08.110192.000435 · DOI · Paper page
- Lombard-Platet, 1996, A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern, Proc. Natl. Acad. Sci. U. S. A., 96, 1265, 10.1073/pnas.93.3.1265 · DOI · Paper page
- Holzinger, 1997, cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDR), a peroxisomal ABC-transporter, Biochem. Bioph. Res. Commun., 239, 261, 10.1006/bbrc.1997.7391 · DOI · Paper page
- Gärtner, 1992, Mutations in the 70 kDa peroxisomal membrane protein gene in Zellweger syndrome, Nat. Genet., 1, 16, 10.1038/ng0492-16 · DOI · Paper page
- Shani, 1997, Identification of a fourth half ABC transporter in the human peroxisomal membrane, Hum. Mol. Genet., 6, 1925, 10.1093/hmg/6.11.1925 · DOI
- Pollard, 1995, Localisation of mRNAs for adrenoleuko-dystrophy and the 70 kDa peroxisomal (PMP70) proteins in the rat brain during post-natal development, J. Neurosci. Res., 42, 433, 10.1002/jnr.490420318 · DOI
- Troffer-Charlier, 1998, Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines, Eur. J. Cell Biol., 75, 254, 10.1016/S0171-9335(98)80121-0 · DOI · Paper page
- Liu, 1999, Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters, J. Biol. Chem., 274, 32738, 10.1074/jbc.274.46.32738 · DOI · Paper page
- Tanaka, 2002, ATP binding/hydrolysis by and phosphorylation of peroxiosmal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1), J. Biol. Chem., 277, 40142, 10.1074/jbc.M205079200 · DOI
- Guimaraes, 2004, Mouse liver PMP70 and ALDP: omomeric interactions prevail in vivo, Biochem. Biophys. Acta, 1689, 235
- Watkins, 1995, Altered expression of ALDP in X-linked adrenoleukodystrophy, Am. J. Hum. Genet., 57, 292
- Kammerer, 1998, Cloning and characterization of the gene encoding the human peroxisomal assembly protein Pex3p, FEBS Lett., 429, 53, 10.1016/S0014-5793(98)00557-2 · DOI
- Lazo, 1988, Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy, Proc. Natl. Acad. Sci. U. S. A., 85, 7647, 10.1073/pnas.85.20.7647 · DOI · Paper page
- Wanders, 1988, Direct evidence that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids, Biochem. Bioph. Res. Commun., 153, 618, 10.1016/S0006-291X(88)81140-9 · DOI · Paper page
- Uchiyama, 1996, Molecular cloning of cDNA encoding rat very long-chain Acyl-CoA synthetase, J. Biol. Chem., 271, 30360, 10.1074/jbc.271.48.30360 · DOI · Paper page
- Berger, 1998, cDNA cloning and mRNA distribution of a mouse very long-chain Acyl-CoA synthetase, FEBS Lett., 425, 305, 10.1016/S0014-5793(98)00255-5 · DOI
- Steinberg, 1999, Human very-long-chain acyl-CoA synthetase: cloning, topography, and relevance to branched-chain fatty acid metabolism, Biochem. Biophys. Res. Commun., 257, 615, 10.1006/bbrc.1999.0510 · DOI
- Heinzer, 2002, Mouse very long-chain acyl-CoA synthetase in X-linked adrenoleukodystrophy, J. Biol. Chem., 277, 28765, 10.1074/jbc.M203053200 · DOI
- Berger, 1998, A novel relative of the very-long-chain acyl-CoA synthetase and fatty acid transporter protein gene with a distinct expression pattern, Biochem. Biophys. Res. Commun., 247, 255, 10.1006/bbrc.1998.8770 · DOI
- Hirsch, 1998, A family of fatty acid transporters conserved from mycobacterium to man, Proc. Natl. Acad. Sci. U. S. A., 95, 8625, 10.1073/pnas.95.15.8625 · DOI · Paper page
- Pei, 2004, Mouse very long-chain Acyl-CoA synthetase 3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 cells, J. Biol. Chem., 279, 54454, 10.1074/jbc.M410091200 · DOI
- Fraisl, 2006, A novel mammalian Bubblegum-related acyl-CoA synthetase restricted to testes and possibly involved in spermatogenesis, Arch. Biochem. Biophys., 451, 23, 10.1016/j.abb.2006.04.013 · DOI
- Min, 1999, Preventing neurodegeneration in the Drosophila mutant bubblegum, Science, 284, 1985, 10.1126/science.284.5422.1985 · DOI · Paper page
- Steinberg, 2000, Very long-chain acyl-CoA synthetases. Human “bubblegum” represents a new family of proteins capable of activating very long-chain fatty acids, J. Biol. Chem., 275, 35162, 10.1074/jbc.M006403200 · DOI
- Moriya-Sato, 2000, Novel acyl-CoA synthetase in adrenoleukodystrophy target tissues, Biochem. Biophys. Res. Commun., 279, 62, 10.1006/bbrc.2000.3897 · DOI
- Tang, 2001, Cloning and characterization of a hormonally regulated rat long chain acyl-CoA synthetase, Proc. Natl. Acad Sci. U. S. A., 98, 6581, 10.1073/pnas.121046998 · doi:10.1073/pnas.121046998
- Pei, 2003, The acyl-CoA synthetase “Bubblegum” (Lipidosin), J. Biol. Chem., 278, 47070, 10.1074/jbc.M310075200 · DOI
- Fraisl, 2004, Murine bubblegum orthologue is a microsomal very long-chain acyl-CoA synthetase, Biochem. J., 377, 85, 10.1042/bj20031062 · DOI
- Oezen, 2005, Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency, Hum. Mol. Genet., 14, 1127, 10.1093/hmg/ddi125 · DOI
- Heinzer, 2003, A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy, Hum. Mol. Genet., 12, 1145, 10.1093/hmg/ddg126 · DOI
- Brown, 1982, Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids, Johns Hopkins Med. J., 151, 164
- Tsuji, 1984, Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy (ALD), J. Biochem., 96, 1241, 10.1093/oxfordjournals.jbchem.a134942 · DOI
- Koike, 1991, Physiological significance of fatty acid elongation system in adrenoleukodystrophy, J. Neurol. Sci., 103, 188, 10.1016/0022-510X(91)90163-2 · DOI
- Kemp, 2005, Elongatin of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy, Mol. Gen. Metabol., 84, 144, 10.1016/j.ymgme.2004.09.015 · DOI · Paper page
- Weinhofer, 2005, X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism, FEBS Lett., 579, 5512, 10.1016/j.febslet.2005.09.014 · DOI
- Powers, 1985, Adrenoleukodystrophy (Adreno-testiculo-leuko-myelo-neuropathic-complex), Clin. Neuropathol., 4, 181
- Powers, 2000, Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy, J. Neuropathol. Exp. Neurol., 59, 89, 10.1093/jnen/59.2.89 · DOI · Paper page
- Powers, 2001, Dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria, J. Neuropathol. Exp. Neurol., 60, 493, 10.1093/jnen/60.5.493 · DOI · Paper page
- Powers, 1982, Fetal adrenoleukodystrophy: the significance of pathologic lesions in adrenal gland and testis, Hum. Pathol., 13, 1013, 10.1016/S0046-8177(82)80093-2 · DOI · Paper page
- Powers, 1980, A correlative study of the adrenal cortex in adreno-leukodystrophy: evidence for a fatal intoxication with very long chain saturated fatty acids, Invest. Cell Pathol., 3, 353
- Powers, 1981, The testis in adrenoleukodystrophy, Am. J. Pathol., 102, 90
- Smith, 1991, A genetic basis for the multiple phenotypes of X-linked adrenoleukodystrophy, Am. J. Hum. Genet., 49, 165
- Maestri, 1992, Predictions of a 2-locus model for disease heterogeneity: applications to adrenoleukodystrophy, Am. J. Hum. Genet., 44, 576, 10.1002/ajmg.1320440509 · DOI
- Forss-Petter, 1997, Accumulation of very long chain fatty acids in mice with a targeted inactivation of the X-linked adrenoleukodystrophy gene, J. Neurosci. Res., 50, 829, 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W · doi:10.1002/(sici)1097-4547(19971201)50:5<829::aid-jnr19>3.0.co;2-w
- Cartier, 2000, Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice, FEBS Lett., 478, 205, 10.1016/S0014-5793(00)01852-4 · DOI
- Netik, 2000, Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice, J. Inherited Metab. Dis., 23, 615, 10.1023/A:1005686114356 · DOI
- Yamada, 2000, Lovastatin does not correct the accumulation of very long-chain fatty acids in tissues of adrenoleukodystrophy protein-deficient mice, J. Inherited Metab. Dis., 23, 607, 10.1023/A:1005634130286 · DOI
- Powers, 2005, Adreno-leukodystrophy: oxidative stress of mice and men, J. Neuropathol. Exp. Neurol., 64, 1067, 10.1097/01.jnen.0000190064.28559.a4 · DOI
- Shani, 1995, PXA1, a possible Saccharomyces cerevisiae ortholog of the human adrenoleukodystrophy gene, Proc. Natl. Acad. Sci. U. S. A., 92, 6012, 10.1073/pnas.92.13.6012 · DOI · Paper page
- Swartzman, 1996, The PAL1 gene product is a peroxisomal ATP-binding cassette transporter in the yeast Saccharomyces cerevisiae, J. Cell Biol., 132, 549, 10.1083/jcb.132.4.549 · DOI
- Hettema, 1996, The ABC transporter proteins Pat1 and Pat2 are required for import of long-chain fatty acids into peroxisomes of Saccharomyces cerevisiae, EMBO J., 15, 3813, 10.1002/j.1460-2075.1996.tb00755.x · DOI · Paper page
- Verleur, 1997, Transport of activated fatty acids by the peroxisomal ATP-binding-cassette transporter Pxa2 in a semi-intact yeast cell system, Eur. J. Biochem., 249, 657, 10.1111/j.1432-1033.1997.00657.x · DOI · Paper page
- Rizzo, 1986, Adrenoleukodystrophy: oleic acid lowers fibroblast C22-26 fatty acids, Neurology, 36, 357, 10.1212/WNL.36.3.357 · DOI
- Asano, 1994, Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy, Brain Dev., 16, 454, 10.1016/0387-7604(94)90007-8 · DOI
- Rasmussen, 1994, Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil), Neurochem. Res., 19, 1073, 10.1007/BF00968719 · DOI
- Korenke, 1995, Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters, Eur. J. Pediatr., 154, 64, 10.1007/BF01972976 · DOI
- van Geel, 1999, Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with “Lorenzo'soil”, J. Neurol., Neurosurg. Psychiatry, 67, 290, 10.1136/jnnp.67.3.290 · DOI · Paper page
- Korenke, 1997, Progression of X-linked adrenoleukodystrophy under interferon-ß therapy, J. Inherited Metab. Dis., 20, 59, 10.1023/A:1005361607523 · DOI
- Krivit, 1995, The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome, J. Inherited Metab. Dis., 18, 398, 10.1007/BF00710052 · DOI · Paper page
- Peters, 2004, Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999, Blood, 104, 881, 10.1182/blood-2003-10-3402 · DOI · Paper page
- Cartier, 1995, Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts, Proc. Natl. Acad. Sci. U. S. A., 92, 1674, 10.1073/pnas.92.5.1674 · DOI · Paper page
- Weinhofer, 2002, Cholesterol regulates ABCD2 expression: Implication for therapy of X-linked adrenoleukodystrophy, Hum. Mol. Genet., 11, 2701, 10.1093/hmg/11.22.2701 · DOI · Paper page
- Singh, 1998, Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X-adrenoleukodystrophy, FEBS Lett., 426, 342, 10.1016/S0014-5793(98)00370-6 · DOI
- Pai, 2000, Lovastatin therapy for X-linked adrenoleukodystrophy: Clinical and biochemical observations on 12 patients, Mol. Genet. Metab., 69, 312, 10.1006/mgme.2000.2977 · DOI
- Singh, 1998, Lovastatin for X-linked adrenoleukodystrophy, N. Engl. J. Med., 339, 702, 10.1056/NEJM199809033391012 · DOI
- Yamada, 2000, Lovastatin does not correct the accumulation of very long-chain fatty acids in tissues of adrenoleukodystrophy protein-deficient mice, J. Inherited Metab. Dis., 23, 607, 10.1023/A:1005634130286 · DOI
- Weinhofer, 2005, LXRalpha interferes with SREBP1c-mediated Abcd2 expression: novel cross-talk in gene regulation, J. Biol. Chem., 280, 41243, 10.1074/jbc.M509450200 · DOI
- Rampler, 2003, Evaluation of the therapeutic potential of PPAR alpha agonists for X-linked adrenoleukodystrophy, Mol. Genet. Metab., 80, 398, 10.1016/j.ymgme.2003.09.002 · DOI
- Fourcade, 2003, Thyroid hormone induction of the drenoleukodystrophy-related gene (ABCD2), Mol. Pharmacol., 63, 1296, 10.1124/mol.63.6.1296 · DOI
Cited by
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
GILLET, J., EFFERTH, T., & REMACLE, J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.002 · Cited by 337
Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism
Van Veldhoven, P. P. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r005959 · Cited by 327
Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models
Chrast, R., Saher, G., Nave, K.-A., & Verheijen, M. H. G. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009761 · Cited by 314
Miller, W. P., Rothman, S. M., Nascene, D., Kivisto, T., DeFor, T. E., Ziegler, R. S., Eisengart, J., Leiser, K., Raymond, G., Lund, T. C., et al. (2011) · Blood · doi:10.1182/blood-2011-01-329235 · Cited by 290
Metadata
- Authors
- Berger, J., & Gärtner, J.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 1763
- Issue
- 12
- Pages
- 1721-1732
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2138312139
- Cited by
- 199
- References
- 39
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2456 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.